302 related articles for article (PubMed ID: 19015066)
1. Origin of renal cell carcinomas.
Valladares Ayerbes M; Aparicio Gallego G; Díaz Prado S; Jiménez Fonseca P; García Campelo R; Antón Aparicio LM
Clin Transl Oncol; 2008 Nov; 10(11):697-712. PubMed ID: 19015066
[TBL] [Abstract][Full Text] [Related]
2. The genetic basis of cancer of the kidney.
Linehan WM; Walther MM; Zbar B
J Urol; 2003 Dec; 170(6 Pt 1):2163-72. PubMed ID: 14634372
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics and histopathologic features of adult distal nephron tumors.
Polascik TJ; Bostwick DG; Cairns P
Urology; 2002 Dec; 60(6):941-6. PubMed ID: 12475646
[No Abstract] [Full Text] [Related]
4. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of BHD in sporadic renal tumors.
Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
[TBL] [Abstract][Full Text] [Related]
6. Pathologic features of renal cortical tumors.
Tickoo SK; Gopalan A
Urol Clin North Am; 2008 Nov; 35(4):551-61; v. PubMed ID: 18992609
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations and histopathologic findings in familial renal cell carcinoma.
Hansel DE
Histol Histopathol; 2006 Apr; 21(4):437-44. PubMed ID: 16437389
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.
da Silva NF; Gentle D; Hesson LB; Morton DG; Latif F; Maher ER
J Med Genet; 2003 Nov; 40(11):820-4. PubMed ID: 14627671
[TBL] [Abstract][Full Text] [Related]
9. Renal carcinogenesis: genotype, phenotype and dramatype.
Hino O; Kobayashi T; Momose S; Kikuchi Y; Adachi H; Okimoto K
Cancer Sci; 2003 Feb; 94(2):142-7. PubMed ID: 12708488
[TBL] [Abstract][Full Text] [Related]
10. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ
Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184
[TBL] [Abstract][Full Text] [Related]
11. Evolving understanding and surgical management of renal cortical tumors.
Russo P
Mayo Clin Proc; 2000 Dec; 75(12):1233-5. PubMed ID: 11126829
[No Abstract] [Full Text] [Related]
12. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
Foster K; Prowse A; van den Berg A; Fleming S; Hulsbeek MM; Crossey PA; Richards FM; Cairns P; Affara NA; Ferguson-Smith MA
Hum Mol Genet; 1994 Dec; 3(12):2169-73. PubMed ID: 7881415
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of familial renal cell carcinoma syndromes.
Cohen D; Zhou M
Clin Lab Med; 2005 Jun; 25(2):259-77. PubMed ID: 15848736
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
15. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
Kennedy JM; Wang X; Plouffe KR; Dhanasekaran SM; Hafez K; Palapattu GS; Else T; Weizer AZ; Morgan TM; Spratt DE; Davenport MS; Chinnaiyan AM; Udager AM; Mehra R
Med Oncol; 2019 Jul; 36(9):74. PubMed ID: 31332543
[TBL] [Abstract][Full Text] [Related]
16. Hereditary Renal Cancer Syndromes.
Yanus GA; Kuligina ES; Imyanitov EN
Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390862
[TBL] [Abstract][Full Text] [Related]
17. [Hippel-Lindau syndrome and sporadic renal cell carcinomas. Pathogenesis, morphologic spectrum and molecular genetics].
Brauch H; Böhm J; Höfler H
Pathologe; 1995 Sep; 16(5):321-7. PubMed ID: 7479604
[TBL] [Abstract][Full Text] [Related]
18. Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
Schmidt L; Junker K; Nakaigawa N; Kinjerski T; Weirich G; Miller M; Lubensky I; Neumann HP; Brauch H; Decker J; Vocke C; Brown JA; Jenkins R; Richard S; Bergerheim U; Gerrard B; Dean M; Linehan WM; Zbar B
Oncogene; 1999 Apr; 18(14):2343-50. PubMed ID: 10327054
[TBL] [Abstract][Full Text] [Related]
19. Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy.
Pfaffenroth EC; Linehan WM
Expert Opin Biol Ther; 2008 Jun; 8(6):779-90. PubMed ID: 18476789
[TBL] [Abstract][Full Text] [Related]
20. Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features.
Adeniran AJ; Shuch B; Humphrey PA
Am J Surg Pathol; 2015 Dec; 39(12):e1-e18. PubMed ID: 26559379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
